All Clinical Trial
Official title:
Patient Satisfaction in the Orthopedic Surgery Clinic
NCT number | NCT04343027 |
Other study ID # | 20-00152 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2022 |
Est. completion date | June 2023 |
Verified date | December 2022 |
Source | NYU Langone Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients in the orthopedic surgery clinic routinely fill out a patient- reported outcome measurement survey prior to their visit. These scores are stored in Epic, but are not routinely reviewed with patients during their office visit. Study subjects will be randomly assigned into one of two groups: those who have their patient- reported outcome measurements reviewed with them by their physician, and those who will not have their patient-reported outcome measurements reviewed during the visit. Following the visit, patients will complete a patient satisfaction survey.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 2023 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Adult patients - Ages 18 and 100 years - Men and women will be included in this study - Willing and able to provide consent - Able to communicate in English - All patients of the Principal Investigator(s) that have an clinic appointment during the study date range will be considered for inclusion in the study Exclusion Criteria: - Patients whose visit is related to workman's compensation, a disability claim, or a "no-fault" case (i.e. a law suit related to personal injury) - Patients that do not complete the patient satisfaction survey following their visit - Patient with mental disabilities or other handicap that would interfere with their capability of completing the surveys |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in participants' satisfaction | Participants' satisfaction will be measured by completing a patient satisfaction survey. This patient satisfaction survey is a modified version of the Press-Ganey Outpatient Medical Practice 10-question survey. The patient satisfaction survey scores will then be compared between the two groups to quantify the effect of reviewing of patient-reported outcome measurements with patients on their satisfaction with the office visit. | 1 day (Visit 1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05016947 -
Venetoclax Plus Inotuzumab for B-ALL
|
Phase 1 | |
Recruiting |
NCT05009537 -
Optical Genome Mapping in Hematological Malignancies
|
||
Terminated |
NCT01230788 -
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
|
N/A | |
Completed |
NCT00333190 -
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT05461625 -
ACL Reconstruction With/Without ALL Reconstruction
|
N/A | |
Recruiting |
NCT02990572 -
Amish/Mennonite Research Contact Registry
|
||
Completed |
NCT02631993 -
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
|
N/A | |
Completed |
NCT00863148 -
Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)
|
Phase 2 | |
Recruiting |
NCT04601584 -
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05592470 -
commd7 Gene Expression in ALL
|
||
Recruiting |
NCT02861209 -
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
|
N/A | |
Completed |
NCT01012492 -
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
|
Phase 2 | |
Recruiting |
NCT04644016 -
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
|
Phase 2 | |
Recruiting |
NCT06131801 -
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
|
||
Recruiting |
NCT05476770 -
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
|
Phase 1 | |
Recruiting |
NCT03571321 -
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
|
Phase 1 | |
Recruiting |
NCT05414162 -
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
|
||
Active, not recruiting |
NCT03154346 -
Project Baseline Health Study
|
||
Terminated |
NCT01532635 -
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
|
Phase 2 | |
Completed |
NCT01319864 -
POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
|
Phase 1 |